Nutritional Intervention in Acute Myocardial Infarction

References

• American Heart Association. Heart Facts. American Heart Association National Centre, Dallas 1987
   Google Scholar
• Peli S, Payerweather WE. Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population. 1957–1983. N Engl J Med 1985; 312: 1005–8
   PubMedGoogle Scholar
• Elveback D. R., Connolly DC. Coronary heart disease in residents of Rochester. Minn V. Prognosis of patients with coronary heart disease based on initial manifestations. Mayo Clin Proc 1985; 60: 5–315; 3
   Google Scholar
• Kannel WB. Meaning of the downward trend in cardiovascular mortality. JAMA 1982; 247: 877–80
   PubMed Web of Science ®Google Scholar
• Pamidis I, Morgauroth J. Sudden death in hospitalized patients: Cardiac rhythm disturbances detected by ambulatory electrocardiographic monitoring. J Am Coll Cardiol 1983; 2: 798–800
   PubMedGoogle Scholar
• Hamer A, Vohra J, Hunt D, et al. Prediction of sudden death by electrophysiologic studies in high risk patients surviving acute myocardial infarction. Am J Cardiol 1982; 50: 223–30
   PubMedGoogle Scholar
• Baker J. T., Bramlet D. A., Lester R. M., Harrison D. C., Roe C. R., Cob FR. Myocardial infarction extension: incidence and relationship to survival. Circulation 1982; 65: 918–25
   PubMedGoogle Scholar
• Rasmussen H. S., McNair P, Norregard P, et al. Intravenous magnesium in acute myocardial infarction. Lancet 1986; i: 234–6
   Google Scholar
• Heng M. K., Norris R. M., Singh B. N., Barret-Boyes C. Effects of glucose and glucose-insulin potassium on haemodynamics and enzyme release after acute myocardial infarction. Br Heart J 1977; 39: 748–54
   PubMedGoogle Scholar
• Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischaemia and infarct size. Am J Cardiol 1975; 36: 938–45
   PubMed Web of Science ®Google Scholar
• Wildenthal K, Mierwqiak D. S., Mitchel JH. Acute effects of increased serum osmalility on left ventricular performance. Am J Physiol 1974; 226: 390–6
   Google Scholar
• Dyckner T, Wester PO. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. Am Heart J 1979; 97: 12–8
   PubMed Web of Science ®Google Scholar
• Singh R. B., Rastogi SS. Nutritional Aspects of Essential Hypertension. Medical Hospital and Research Centre (Publication), Moradabad 1989; 102–13
   Google Scholar
• Singh RB. Multifactorial risk factor intervention for sudden death. The Indian Diet-Heart Preliminary study. J Adv Med 1989; 2: 475–85
   Google Scholar
• Horrobin D. F., Huang YS. The role of linoleic acid and its metabolites in the lowering of plasma cholesterol and the prevention of cardiovascular disease. Int J Cardiol 1987; 17: 241–55
   PubMed Web of Science ®Google Scholar
• Dehmer G. J., Vandenberg E. K., Pooma J. J., Jacquin P, Prewitt B. S., Willerson J. T., Schmitze JM. Dietary supplementation with n-3 fatty acids reduces the rate of restenosis after coronary angioplasty. J Am Coll Cardiol 1988; 11: 287A
   Google Scholar
• Kjekohus JK. Effect of lipolytic and inotropic stimulation on myocardial ischemic injury. Experimental and Clinical Aspects on Preservation of Ischaemic Myocardium, A Hjalmarson, L Werko, Sweden 1976; 29–35, Molndal
   Google Scholar
• Folts J. D., Snug A. S., Koke J. R., Bittar N. Protection of the ischaemic dog myocardium with l-carnitine. Clin Res 1976; 24: 217A
   Google Scholar
• Gopalan C, Ramasastri B. V., Balasubramanium SC. Nutrition Value of Indian Foods. National Institute of Nutrition, Hyderabad 1976
   Google Scholar
• Singh R. B., Singh V. P., Cameron EA. Magnesium in atherosclerotic cardiovascular disease and sudden death. Acta Cardiol 1981; 36: 411–29
   PubMedGoogle Scholar
• Ranjo L. I., Paolo C, Spinks T. J., Jones T, Maseri A. Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography. Cardiovasc Drug Ther 1988; 2: 41–6
   PubMedGoogle Scholar
• Sjogren A, Edvinsson L, Offosson A. Enhanced vasoconstrictor responses to potassium, 5-hydroxytryptamine and prostaglandin F2 alpha of isolated coronary arteries from magnesium deficient rats. Comparison with vasomotor activity of aorta. J Am Coll Nutr 1988; 7: 461–9
   PubMedGoogle Scholar
• Selye H. Prophylactic treatment of an experimental arteriosclerosis with magnesium and potassium salts. Am Heart J 1958; 55: 805–9
   PubMedGoogle Scholar
• Lipid Research Clinics Programme. The lipid research clinic primary prevention results. Reduction in incidence of coronary heart disease. JAMA 1985; 251: 351–64
   Google Scholar
• Collins P. EDRF: the endogenous nitrate. Cardiology Today 1989; 17: 7
   Google Scholar